These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2642891)

  • 61. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensin.
    Jackson EK; Herzer WA; Mi Z; Vyas SJ; Kost CK
    J Pharmacol Exp Ther; 1999 Oct; 291(1):115-23. PubMed ID: 10490894
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Is there a role for renin profiling in selecting chronic heart failure patients for ACE inhibitor treatment?
    Lim PO; MacFadyen RJ; Struthers AD
    Heart; 2000 Mar; 83(3):257-61. PubMed ID: 10677399
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension.
    Taylor T; Moore TJ; Hollenberg NK; Williams GH
    Hypertension; 1984; 6(1):92-9. PubMed ID: 6198274
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
    Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Indirect evidence for vascular uptake of circulating renin in hypertensive patients.
    Taddei S; Virdis A; Abdel-Haq B; Giovannetti R; Duranti P; Arena AM; Favilla S; Salvetti A
    Hypertension; 1993 Jun; 21(6 Pt 1):852-60. PubMed ID: 8388858
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Caffeine attenuates the renal vascular response to angiotensin II infusion.
    Brown NJ; Ryder D; Nadeau J
    Hypertension; 1993 Dec; 22(6):847-52. PubMed ID: 8244516
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation.
    Swartz SL; Williams GH; Hollenberg NK; Moore TJ; Dluhy RG
    Hypertension; 1979; 1(2):106-11. PubMed ID: 233366
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Plasma renin activity and metabolic clearance rate of angiotensin II in the unstressed aging rat.
    Baylis C; Engels K; Hymel A; Navar LG
    Mech Ageing Dev; 1997 Aug; 97(2):163-72. PubMed ID: 9226634
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dopaminergic modulation of some central actions of angiotensin II in vivo.
    Huang BS; Malvin RL
    Proc Soc Exp Biol Med; 1988 Sep; 188(4):405-9. PubMed ID: 3047744
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dopaminergic modulation of renin release.
    Sowers JR; Barrett JD; Sambhi MP
    Clin Exp Hypertens (1978); 1981; 3(1):15-25. PubMed ID: 7009102
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Circulating renin in essential hypertension: an evaluation of its significance in the Japanese population.
    Abe K; Irokawa N; Aoyagi H; Memezawa H; Yasujima M
    Am Heart J; 1975 Jun; 89(6):723-30. PubMed ID: 1130265
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evidence for heritability of non-modulating essential hypertension.
    Lifton RP; Hopkins PN; Williams RR; Hollenberg NK; Williams GH; Dluhy RG
    Hypertension; 1989 Jun; 13(6 Pt 2):884-9. PubMed ID: 2737726
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Angiotensin, ACE inhibition, and the renal circulation: pathogenesis of nonmodulation in essential hypertension.
    Hollenberg NK; Williams GH
    Contrib Nephrol; 1990; 79():1-10. PubMed ID: 2225846
    [No Abstract]   [Full Text] [Related]  

  • 76. Alterations in cerebrospinal fluid angiotensin II by sodium intake in patients with essential hypertension.
    Kawamura M; Kawano Y; Yoshida K; Imanishi M; Akabane S; Matsushima Y; Kuramochi M; Shimamoto K; Ito K; Omae T
    Clin Sci (Lond); 1989 Oct; 77(4):389-94. PubMed ID: 2553328
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical pharmacology of enalkiren, a novel, dipeptide renin inhibitor.
    Glassman HN; Kleinert HD; Boger RS; Moyse DM; Griffiths AN; Luther RR
    J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S76-81. PubMed ID: 1705633
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunoradiometric assay of active renin versus determination of plasma renin activity in the clinical investigation of hypertension, congestive heart failure, and liver cirrhosis.
    Plouin PF; Cudek P; Arnal JF; Guyene TT; Corvol P
    Horm Res; 1990; 34(3-4):138-41. PubMed ID: 2104397
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reninlike enzymes in human vasculature.
    Rosenthal J; Thurnreiter M; Plaschke M; Geyer M; Reiter W; Dahlheim H
    Hypertension; 1990 Jun; 15(6 Pt 2):848-53. PubMed ID: 2190929
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Low-renin and nonmodulating essential hypertension.
    Warnock DG
    Hypertension; 1999 Sep; 34(3):395-7. PubMed ID: 10489383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.